9 results on '"Zeitouni, Michel"'
Search Results
2. Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- Author
-
Bulluck, Heerajnarain, primary, Paradies, Valeria, additional, Barbato, Emanuele, additional, Baumbach, Andreas, additional, Bøtker, Hans Erik, additional, Capodanno, Davide, additional, De Caterina, Raffaele, additional, Cavallini, Claudio, additional, Davidson, Sean M, additional, Feldman, Dmitriy N, additional, Ferdinandy, Péter, additional, Gili, Sebastiano, additional, Gyöngyösi, Mariann, additional, Kunadian, Vijay, additional, Ooi, Sze-Yuan, additional, Madonna, Rosalinda, additional, Marber, Michael, additional, Mehran, Roxana, additional, Ndrepepa, Gjin, additional, Perrino, Cinzia, additional, Schüpke, Stefanie, additional, Silvain, Johanne, additional, Sluijter, Joost P G, additional, Tarantini, Giuseppe, additional, Toth, Gabor G, additional, Van Laake, Linda W, additional, von Birgelen, Clemens, additional, Zeitouni, Michel, additional, Jaffe, Allan S, additional, Thygesen, Kristian, additional, and Hausenloy, Derek J, additional
- Published
- 2021
- Full Text
- View/download PDF
3. Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data
- Author
-
Silvain, Johanne, primary, Zeitouni, Michel, additional, Paradies, Valeria, additional, Zheng, Huili L, additional, Ndrepepa, Gjin, additional, Cavallini, Claudio, additional, Feldman, Dimitri N, additional, Sharma, Samin K, additional, Mehilli, Julinda, additional, Gili, Sebastiano, additional, Barbato, Emanuele, additional, Tarantini, Giuseppe, additional, Ooi, Sze Y, additional, von Birgelen, Clemens, additional, Jaffe, Allan S, additional, Thygesen, Kristian, additional, Montalescot, Gilles, additional, Bulluck, Heerajnarain, additional, and Hausenloy, Derek J, additional
- Published
- 2020
- Full Text
- View/download PDF
4. Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease
- Author
-
Collet, Jean-Philippe, Roffi, Marco, Byrne, Robert A, Costa, Francesco, Valgimigli, Marco, Bueno, Héctor, Jeppsson, Anders, Jüni, Peter, Kastrati, Adnan, Kolh, Philippe, Mauri, Laura, Montalescot, Gilles, Neumann, Franz-Josef, Petricevic, Mate, Steg, Philippe Gabriel, Windecker, Stephan, Zamorano, Jose Luis, Badimon, Lina, Vranckx, Pascal, Agewall, Stefan, De Luca, Leonardo, Desmet, Walter, James, Stefan, Lettino, Maddalena, McFadden, Eugene Patrick, Storey, Robert, Ten Berg, Jurrien M, Aboyans, Victor, Jofresa, Alberto Berenguer, Biščević, Adela, Calabrò, Paolo, Constantinides, Savvas, Damrina, Elena, Diakite, Moustapha, Dzudovic, Boris, Ruiz, Victoria Garcia, Yáñez, Ivan Keituqwa, Lacalzada-Almeida, Juan, Leite, Luís, Maskon, Oteh, Myat, Lin Lin, Ricottini, Elisabetta, Saporito, Francesco, Wong, Peter Sze Chai, Yamaji, Kyohei, Zeitouni, Michel, Task Force for the Management of Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC), ESC Scientific Document Group, Collet, Jean-Philippe, Roffi, Marco, Byrne, Robert A., Costa, Francesco, Valgimigli, Marco, Bueno, Hã©ctor, Jeppsson, Ander, Jã¼ni, Peter, Kastrati, Adnan, Kolh, Philippe, Mauri, Laura, Montalescot, Gille, Neumann, Franz-Josef, Petricevic, Mate, Steg, Philippe Gabriel, Windecker, Stephan, Zamorano, Jose Lui, Badimon, Lina, Vranckx, Pascal, Agewall, Stefan, De Luca, Leonardo, Desmet, Walter, James, Stefan, Lettino, Maddalena, Mcfadden, Eugene Patrick, Storey, Robert, Ten Berg, Jurrien M., Aboyans, Victor, Jofresa, Alberto Berenguer, BiÅ¡Ä ević, Adela, Calabro', Paolo, Constantinides, Savva, Damrina, Elena, Diakite, Moustapha, Dzudovic, Bori, Ruiz, Victoria Garcia, Yã¡ã±ez, Ivan Keituqwa, Lacalzada-Almeida, Juan, Leite, Luã, Maskon, Oteh, Myat, Lin Lin, Ricottini, Elisabetta, Saporito, Francesco, Wong, Peter Sze Chai, Yamaji, Kyohei, and Zeitouni, Michel
- Subjects
medicine.medical_specialty ,Aspirin ,business.industry ,MEDLINE ,dual antiplatelet therapy ,coronary artery disease ,Coronary Artery Disease ,030204 cardiovascular system & hematology ,DUAL (cognitive architecture) ,medicine.disease ,Coronary artery disease ,03 medical and health sciences ,0302 clinical medicine ,Pharmacotherapy ,Text mining ,Internal medicine ,Cardiology ,Medicine ,Humans ,Drug Therapy, Combination ,030212 general & internal medicine ,business ,Cardiology and Cardiovascular Medicine ,Platelet Aggregation Inhibitors ,medicine.drug - Abstract
Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease. Guidelines are presented throughout several case scenarios so the readership may better understand the research questions through case scenarios.
- Published
- 2017
5. Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: a pooled analysis of patient-level data.
- Author
-
Silvain, Johanne, Zeitouni, Michel, Paradies, Valeria, Zheng, Huili L, Ndrepepa, Gjin, Cavallini, Claudio, Feldman, Dimitri N, Sharma, Samin K, Mehilli, Julinda, Gili, Sebastiano, Barbato, Emanuele, Tarantini, Giuseppe, Ooi, Sze Y, Birgelen, Clemens von, Jaffe, Allan S, Thygesen, Kristian, Montalescot, Gilles, Bulluck, Heerajnarain, and Hausenloy, Derek J
- Subjects
MYOCARDIAL infarction treatment ,MYOCARDIAL infarction-related mortality ,PERCUTANEOUS coronary intervention ,SURGICAL stents ,ISCHEMIA - Abstract
Aims The prognostic importance of cardiac procedural myocardial injury and myocardial infarction (MI) in chronic coronary syndrome (CCS) patients undergoing elective percutaneous coronary intervention (PCI) is still debated. Methods and results We analysed individual data of 9081 patients undergoing elective PCI with normal pre-PCI baseline cardiac troponin (cTn) levels. Multivariate models evaluated the association between post-PCI elevations in cTn and 1-year mortality, while an interval analysis evaluated the impact of the size of the myocardial injury on mortality. Our analysis was performed in the overall population and also according to the type of cTn used [52.0% had high-sensitivity cTn (hs-cTn)]. Procedural myocardial injury, as defined by the Fourth Universal Definition of MI (UDMI) [post-PCI cTn elevation ≥1 × 99th percentile upper reference limit (URL)], occurred in 52.8% of patients and was not associated with 1-year mortality [adj odds ratio (OR), 1.35, 95% confidence interval (CI) (0.84–1.77), P = 0.21]. The association between post-PCI cTn elevation and 1-year mortality was significant starting ≥3 × 99th percentile URL. Major myocardial injury defined by post-PCI ≥5 × 99th percentile URL occurred in 18.2% of patients and was associated with a two-fold increase in the adjusted odds of 1-year mortality [2.29, 95% CI (1.32–3.97), P = 0.004]. In the subset of patients for whom periprocedural evidence of ischaemia was collected (n = 2316), Type 4a MI defined by the Fourth UDMI occurred in 12.7% of patients and was strongly associated with 1-year mortality [adj OR 3.21, 95% CI (1.42–7.27), P = 0.005]. We also present our results according to the type of troponin used (hs-cTn or conventional troponin). Conclusion Our analysis has demonstrated that in CCS patients with normal baseline cTn levels, the post-PCI cTn elevation of ≥5 × 99th percentile URL used to define Type 4a MI is associated with 1-year mortality and could be used to detect 'major' procedural myocardial injury in the absence of procedural complications or evidence of new myocardial ischaemia. Open in new tab Download slide Open in new tab Download slide [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
6. Periproceduralmyocardial infarction and injury in elective coronary stenting.
- Author
-
Zeitouni, Michel, Silvain, Johanne, Guedeney, Paul, Kerneis, Mathieu, Yan, Yan, Overtchouk, Pavel, Barthelemy, Olivier, Hauguel-Moreau, Marie, Choussat, Rémi, and Helft, Gérard
- Abstract
Aims To assess the incidence, risk factors and prognosis of periprocedural myocardial infarction (MI) and myocardial injury in patients undergoing elective percutaneous coronary intervention (PCI). Methods and results We included all consecutive patients who underwent elective PCI with a negative troponin level at admission from 1 January 2014 to 31 December 2015. The primary endpoint was defined as the composite of periprocedural MI (Type 4a MI), stent thrombosis (Type 4b MI) and myocardial injury according to the Third universal definition of MI. Multivariable analysis was performed to identify independent predictors of periprocedural MI and myocardial injury and its relation to 30-day and 1-year clinical outcome. Of the 1390 elective PCI patients, the primary endpoint occurred in 28.7% of patients, including 7.0% of Type 4a MI, 0.14% of Type 4b MI and 21.6% of myocardial injury. Independent risk factors for the occurrence of the primary endpoint were left main PCI, total stent length >30 mm, multiple stenting, chronic kidney disease (estimated glomerular filtration rate <60 mL/min) and age >75 years. At 30 days, patients with periprocedural MI and myocardial injury had a higher rate of cardiovascular events [5.5% vs. 1.2%, adjusted hazard ratio (adjHR) = 3.8, 95% confidence interval (CI) 1.9-6.9; P < 0.001] mainly driven by ischaemic events (3.2% vs. 0.6%, HR 5.9, 95% CI 2.9-20; P < 0.0001). At 1-year, the risk of ischemic events remained higher in the periprocedural MI and myocardial injury group (adjHR = 1.7, 95% CI 1.1-2.6; P = 0.004). Conclusions Periprocedural MI and injury are frequent complications of elective PCI associated with an increased rate of cardiovascular events at 30 days and 1 year. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
7. Appropriate criteria for the definition of Type 4a MI.
- Author
-
Silvain, Johanne, Hausenloy, Derek, and Zeitouni, Michel
- Subjects
MYOCARDIAL infarction ,MORTALITY ,TROPONIN ,CARDIOVASCULAR disease diagnosis - Abstract
The authors respond to the comment on their study on procedural myocardial infarction (MI), injury, and mortality in patients undergoing elective percutaneous coronary intervention (PCI). Topics include the need for additional data on the prognosis of patients who had an increase of cardiac troponin (cTn) after PCI, a discussion on the use of 3rd Universal definition of MI, and the need for further data to validate the non-cTn-related criteria of the definition of Type 4a MI.
- Published
- 2022
- Full Text
- View/download PDF
8. Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data.
- Author
-
Silvain J, Zeitouni M, Paradies V, Zheng HL, Ndrepepa G, Cavallini C, Feldman DN, Sharma SK, Mehilli J, Gili S, Barbato E, Tarantini G, Ooi SY, von Birgelen C, Jaffe AS, Thygesen K, Montalescot G, Bulluck H, and Hausenloy DJ
- Subjects
- Biomarkers, Humans, Troponin, Coronary Artery Disease, Myocardial Infarction, Percutaneous Coronary Intervention adverse effects
- Abstract
Aims: The prognostic importance of cardiac procedural myocardial injury and myocardial infarction (MI) in chronic coronary syndrome (CCS) patients undergoing elective percutaneous coronary intervention (PCI) is still debated., Methods and Results: We analysed individual data of 9081 patients undergoing elective PCI with normal pre-PCI baseline cardiac troponin (cTn) levels. Multivariate models evaluated the association between post-PCI elevations in cTn and 1-year mortality, while an interval analysis evaluated the impact of the size of the myocardial injury on mortality. Our analysis was performed in the overall population and also according to the type of cTn used [52.0% had high-sensitivity cTn (hs-cTn)]. Procedural myocardial injury, as defined by the Fourth Universal Definition of MI (UDMI) [post-PCI cTn elevation ≥1 × 99th percentile upper reference limit (URL)], occurred in 52.8% of patients and was not associated with 1-year mortality [adj odds ratio (OR), 1.35, 95% confidence interval (CI) (0.84-1.77), P = 0.21]. The association between post-PCI cTn elevation and 1-year mortality was significant starting ≥3 × 99th percentile URL. Major myocardial injury defined by post-PCI ≥5 × 99th percentile URL occurred in 18.2% of patients and was associated with a two-fold increase in the adjusted odds of 1-year mortality [2.29, 95% CI (1.32-3.97), P = 0.004]. In the subset of patients for whom periprocedural evidence of ischaemia was collected (n = 2316), Type 4a MI defined by the Fourth UDMI occurred in 12.7% of patients and was strongly associated with 1-year mortality [adj OR 3.21, 95% CI (1.42-7.27), P = 0.005]. We also present our results according to the type of troponin used (hs-cTn or conventional troponin)., Conclusion: Our analysis has demonstrated that in CCS patients with normal baseline cTn levels, the post-PCI cTn elevation of ≥5 × 99th percentile URL used to define Type 4a MI is associated with 1-year mortality and could be used to detect 'major' procedural myocardial injury in the absence of procedural complications or evidence of new myocardial ischaemia., (Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2021
- Full Text
- View/download PDF
9. Periprocedural myocardial infarction and injury in elective coronary stenting.
- Author
-
Zeitouni M, Silvain J, Guedeney P, Kerneis M, Yan Y, Overtchouk P, Barthelemy O, Hauguel-Moreau M, Choussat R, Helft G, Le Feuvre C, Collet JP, and Montalescot G
- Subjects
- Aged, Female, Humans, Male, Postoperative Complications, Risk Factors, Treatment Outcome, Coronary Thrombosis etiology, Elective Surgical Procedures adverse effects, Heart Injuries etiology, Myocardial Infarction etiology, Myocardial Ischemia surgery, Percutaneous Coronary Intervention adverse effects, Stents adverse effects
- Abstract
Aims: To assess the incidence, risk factors and prognosis of periprocedural myocardial infarction (MI) and myocardial injury in patients undergoing elective percutaneous coronary intervention (PCI)., Methods and Results: We included all consecutive patients who underwent elective PCI with a negative troponin level at admission from 1 January 2014 to 31 December 2015. The primary endpoint was defined as the composite of periprocedural MI (Type 4a MI), stent thrombosis (Type 4b MI), and myocardial injury according to the Third universal definition of MI. Multivariable analysis was performed to identify independent predictors of periprocedural MI and myocardial injury and its relation to 30-day and 1-year clinical outcome. Of the 1390 elective PCI patients, the primary endpoint occurred in 28.7% of patients, including 7.0% of Type 4a MI, 0.14% of Type 4b MI, and 21.6% of myocardial injury. Independent risk factors for the occurrence of the primary endpoint were left main PCI, total stent length >30 mm, multiple stenting, chronic kidney disease (estimated glomerular filtration rate <60 mL/min) and age >75 years. At 30 days, patients with periprocedural MI and myocardial injury had a higher rate of cardiovascular events [5.5% vs. 1.2%, adjusted hazard ratio (adjHR) = 3.8, 95% confidence interval (CI) 1.9-6.9; P < 0.001] mainly driven by ischaemic events (3.2% vs. 0.6%, HR 5.9, 95% CI 2.9-20; P < 0.0001). At 1-year, the risk of ischemic events remained higher in the periprocedural MI and myocardial injury group (adjHR = 1.7, 95% CI 1.1-2.6; P = 0.004)., Conclusions: Periprocedural MI and injury are frequent complications of elective PCI associated with an increased rate of cardiovascular events at 30 days and 1 year.
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.